Beijing Chunlizhengda Medical Instruments
Market Cap
HK$8.6b
Last Updated
2020/01/28 13:02 UTC
Data Sources
Company Financials +
Executive Summary
Beijing Chunlizhengda Medical Instruments Co., Ltd., an orthopedic medical device company, engages in the research and development, production, and sale of surgical implants, instruments, and related products in the People’s Republic of China.
Rewards
Risk Analysis
Snowflake Analysis
Flawless balance sheet with high growth potential.
Similar Companies
Share Price & News
How has Beijing Chunlizhengda Medical Instruments's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 1858's share price has been volatile over the past 3 months.
Market Performance
7 Day Return
-1.2%
1858
-1.0%
HK Medical Equipment
-0.4%
HK Market
1 Year Return
411.6%
1858
50.9%
HK Medical Equipment
-0.4%
HK Market
Return vs Industry: 1858 exceeded the Hong Kong Medical Equipment industry which returned 51.9% over the past year.
Return vs Market: 1858 exceeded the Hong Kong Market which returned 6.4% over the past year.
Shareholder returns
| 1858 | Industry | Market | |
|---|---|---|---|
| 7 Day | -1.2% | -1.0% | -0.4% |
| 30 Day | 35.2% | 12.0% | -1.2% |
| 90 Day | 34.0% | 12.9% | 4.2% |
| 1 Year | 423.4%411.6% | 52.4%50.9% | 3.3%-0.4% |
| 3 Year | 944.0%892.0% | 42.3%37.7% | 20.4%8.2% |
| 5 Year | n/a | 43.8%36.3% | 18.8%-1.0% |
Price Volatility Vs. Market
How volatile is Beijing Chunlizhengda Medical Instruments's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 day ago | Simply Wall St
Can You Imagine How Elated Beijing Chunlizhengda Medical Instruments's (HKG:1858) Shareholders Feel About Its 892% Share Price Gain?1 week ago | Simply Wall St
A Rising Share Price Has Us Looking Closely At Beijing Chunlizhengda Medical Instruments Co., Ltd.'s (HKG:1858) P/E Ratio2 weeks ago | Simply Wall St
Should We Be Delighted With Beijing Chunlizhengda Medical Instruments Co., Ltd.'s (HKG:1858) ROE Of 24%?Valuation
Is Beijing Chunlizhengda Medical Instruments undervalued compared to its fair value and its price relative to the market?
46.07x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 1858 (HK$63.95) is trading above our estimate of fair value (HK$7.46)
Significantly Below Fair Value: 1858 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 1858 is poor value based on its PE Ratio (47.3x) compared to the Medical Equipment industry average (17.2x).
PE vs Market: 1858 is poor value based on its PE Ratio (47.3x) compared to the Hong Kong market (10.5x).
Price to Earnings Growth Ratio
PEG Ratio: 1858 is poor value based on its PEG Ratio (2.2x)
Price to Book Ratio
PB vs Industry: 1858 is overvalued based on its PB Ratio (11.4x) compared to the HK Medical Equipment industry average (2.6x).
Next Steps
Future Growth
How is Beijing Chunlizhengda Medical Instruments forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
21.3%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 1858's forecast earnings growth (21.3% per year) is above the savings rate (1.6%).
Earnings vs Market: 1858's earnings (21.3% per year) are forecast to grow faster than the Hong Kong market (11.3% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 1858's revenue (19.6% per year) is forecast to grow faster than the Hong Kong market (10.2% per year).
High Growth Revenue: 1858's revenue (19.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 1858's Return on Equity is forecast to be high in 3 years time (26.5%)
Next Steps
Past Performance
How has Beijing Chunlizhengda Medical Instruments performed over the past 5 years?
29.6%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 1858 has a high level of non-cash earnings.
Growing Profit Margin: 1858's current net profit margins (24.9%) are higher than last year (21.4%).
Past Earnings Growth Analysis
Earnings Trend: 1858's earnings have grown significantly by 29.6% per year over the past 5 years.
Accelerating Growth: 1858's earnings growth over the past year (97.5%) exceeds its 5-year average (29.6% per year).
Earnings vs Industry: 1858 earnings growth over the past year (97.5%) exceeded the Medical Equipment industry 43.4%.
Return on Equity
High ROE: 1858's Return on Equity (23.9%) is considered high.
Return on Assets
Return on Capital Employed
Next Steps
Financial Health
How is Beijing Chunlizhengda Medical Instruments's financial position?
Financial Position Analysis
Short Term Liabilities: 1858's short term assets (CN¥782.5M) exceed its short term liabilities (CN¥245.5M).
Long Term Liabilities: 1858's short term assets (CN¥782.5M) exceed its long term liabilities (CN¥19.0M).
Debt to Equity History and Analysis
Debt Level: 1858 is debt free.
Reducing Debt: 1858 has not had any debt for past 5 years.
Debt Coverage: 1858 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 1858 has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Inventory Level: 1858 has a high level of physical assets or inventory.
Debt Coverage by Assets: Insufficient data to determine if 1858's debt is covered by short term assets.
Next Steps
Dividend
What is Beijing Chunlizhengda Medical Instruments's current dividend yield, its reliability and sustainability?
0.55%
Current Dividend Yield
Upcoming Dividend Payment
Purchase Beijing Chunlizhengda Medical Instruments before the 'Buy Limit' to receive their next dividend payment.
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: 1858's dividend (0.54%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (2.17%).
High Dividend: 1858's dividend (0.54%) is low compared to the top 25% of dividend payers in the Hong Kong market (6.02%).
Stability and Growth of Payments
Stable Dividend: 1858 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are stable.
Growing Dividend: 1858 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: 1858 is not paying a notable dividend for the Hong Kong market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 1858's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.
Next Steps
Management
What is the CEO of Beijing Chunlizhengda Medical Instruments's salary, the management and board of directors tenure and is there insider trading?
6.2yrs
Average management tenure
CEO
Chunbao Shi (49yo)
9.3yrs
Tenure
CN¥1,520,149
Compensation
Mr. Chunbao Shi has been General Manager and Chairman of the Board for Beijing Chunlizhengda Medical Instruments Co., Ltd. since September 2010. Mr. Shi has been Sales & Marketing Director of Beijing Chunl ...
CEO Compensation Analysis
Compensation vs Market: Chunbao's total compensation ($USD220.64K) is below average for companies of similar size in the Hong Kong market ($USD470.54K).
Compensation vs Earnings: Chunbao's compensation has increased by more than 20% in the past year.
Management Age and Tenure
6.2yrs
Average Tenure
47yo
Average Age
Experienced Management: 1858's management team is seasoned and experienced (6.2 years average tenure).
Board Age and Tenure
9.3yrs
Average Tenure
49.5yo
Average Age
Experienced Board: 1858's board of directors are considered experienced (9.3 years average tenure).
Insider Trading
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
| Entity | Company |
| Shares | 57,000 |
| Max Price | HK$49.68 |
| Entity | Company |
| Shares | 80,000 |
| Max Price | HK$39.82 |
| Entity | Company |
| Shares | 45,200 |
| Max Price | HK$31.88 |
| Entity | Company |
| Shares | 600,000 |
| Max Price | HK$27.60 |
| Entity | Company |
| Shares | 20,000 |
| Max Price | HK$16.07 |
| Entity | Individual |
| Shares | 125,200 |
| Max Price | HK$17.50 |
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Management Team
Pui Sum Ip (59yo)
Company Secretary
- Tenure: 4.8yrs
Yumei Liu (30yo)
Chief Financial Officer
- Tenure: 1.5yrs
Shujun Yue (47yo)
Executive Director & Deputy GM
- Tenure: 9.3yrs
- Compensation: CN¥1.24m
Chunbao Shi (49yo)
Chairman
- Tenure: 9.3yrs
- Compensation: CN¥1.52m
Jianliang Wang (40yo)
Domestic Sales Director & Executive Director
- Tenure: 3.2yrs
- Compensation: CN¥319.08k
Board Members
Yiming Lin (50yo)
Non-Executive Director
- Tenure: 9.3yrs
Shujun Yue (47yo)
Executive Director & Deputy GM
- Tenure: 9.3yrs
- Compensation: CN¥1.24m
Chunbao Shi (49yo)
Chairman
- Tenure: 9.3yrs
- Compensation: CN¥1.52m
Xiaobo Tong (59yo)
Independent Non-Executive Director
- Tenure: 9.3yrs
- Compensation: CN¥100.00k
Lanlan Zhang (30yo)
Employee Supervisor
- Tenure: 9.3yrs
- Compensation: CN¥34.47k
Jianliang Wang (40yo)
Domestic Sales Director & Executive Director
- Tenure: 3.2yrs
- Compensation: CN¥319.08k
Changyin Ge (54yo)
Independent Non-Executive Director
- Tenure: 2.6yrs
- Compensation: CN¥100.00k
Jinyong Zhan (50yo)
Chairman of the Board of Supervisors
Xiaohui Pei (46yo)
Supervisor
- Tenure: 3.5yrs
Wai Ho (55yo)
Independent Non-Executive Director
- Tenure: 1.8yrs
- Compensation: CN¥54.44k
Company Information
Beijing Chunlizhengda Medical Instruments Co., Ltd.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Beijing Chunlizhengda Medical Instruments Co., Ltd.
- Ticker: 1858
- Exchange: SEHK
- Founded: 1998
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: HK$8.563b
- Shares outstanding: 138.34m
- Website: https://www.clzd.com/tc/index.php
Number of Employees
Location
- Beijing Chunlizhengda Medical Instruments Co., Ltd.
- No. 10 Xinmi Xi Er Road
- Southern District of Tongzhou
- Beijing
- China
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| 1858 | SEHK (The Stock Exchange of Hong Kong Ltd.) | Yes | Foreign Shares-Foreign Listed | HK | HKD | Mar 2015 |
Biography
Beijing Chunlizhengda Medical Instruments Co., Ltd., an orthopedic medical device company, engages in the research and development, production, and sale of surgical implants, instruments, and related products in the People’s Republic of China. It offers implantable orthopedic medical devices, which consist of joint prosthesis products and spinal products. Beijing Chunlizhengda Medical Instruments Co., Ltd. primarily sells its products through distributors, or on ODM and OEM bases under the Chunli brand, as well as to hospitals directly. The company also exports its products to 36 countries and regions in Asia, South America, Africa, Oceania, and Europe. Beijing Chunlizhengda Medical Instruments Co., Ltd. was founded in 1998 and is headquartered in Beijing, China.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/01/28 13:02 |
| End of Day Share Price | 2020/01/24 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.